thelegalist.net

H.R. 26: A Complete Guide to Proposed Changes and Current Legislative Status

Healthcare costs and access remain among the most urgent issues facing Americans today. Millions struggle with sky-high prescription drug prices, limited mental health services, and unequal access to quality care—barriers that H.R. 26, the Lower Health Care Costs Act, aims to address. Introduced in the 118th U.S. Congress, this bipartisan-focused bill has the potential to reshape key aspects of the U.S. healthcare system. But what exactly does it propose? Where does it stand in the legislative process? And how could it impact you or your community? This guide breaks down every detail to help you understand H.R. 26’s purpose, provisions, and path forward.

Table of Contents#

  1. What Is H.R. 26? An Overview
  2. Key Proposed Changes in H.R. 26 2.1 Healthcare Access and Affordability Provisions 2.2 Mental Health and Substance Use Disorder Expansions 2.3 Public Health Infrastructure Improvements
  3. Legislative Journey: Current Status of H.R. 26 3.1 Introduction and Committee Review 3.2 Floor Action and Next Steps 3.3 Potential Hurdles to Passage
  4. Why H.R. 26 Matters for Individuals and Communities
  5. Frequently Asked Questions (FAQs)
  6. References

What Is H.R. 26? An Overview#

H.R. 26 is a federal legislative bill introduced in the U.S. House of Representatives during the 118th Congress (2023–2024) by Representative Buddy Carter (R-Georgia). Officially titled the Lower Health Care Costs Act, its core mission is to reduce healthcare expenses, expand access to critical services, and strengthen the nation’s public health infrastructure.

Unlike single-issue bills, H.R. 26 takes a multifaceted approach, combining provisions targeted at prescription drug costs, mental health, telehealth, and health equity. It builds on previous reforms (such as the Inflation Reduction Act’s insulin caps) while addressing gaps in current healthcare policy.

Key Proposed Changes in H.R. 26#

2.1 Healthcare Access and Affordability Provisions#

The bill’s most high-profile changes focus on making healthcare more affordable for all Americans:

  • Expanded Medicare Drug Price Negotiation: Under the Inflation Reduction Act (IRA), Medicare can negotiate prices for a small subset of high-cost drugs. H.R. 26 would expand this program to include more medications, including newer drugs (those approved 7–10 years prior, down from the IRA’s 10-year threshold). This could lead to significant cost savings for Medicare beneficiaries and private insurance holders alike.
  • Nationwide Insulin Cap: The IRA capped insulin at $35/month for Medicare beneficiaries, but H.R. 26 extends this cap to all Americans, regardless of insurance type. For the 7.4 million U.S. adults with diabetes who rely on insulin, this could save thousands of dollars annually.
  • Transparent Out-of-Pocket Costs: The bill requires health insurance plans to provide real-time cost estimates for medical procedures, medications, and services. This helps patients avoid surprise billing and plan their healthcare expenses more effectively.
  • Permanent Telehealth Coverage: During the COVID-19 pandemic, telehealth access expanded dramatically, but many temporary provisions are set to expire. H.R. 26 makes telehealth coverage permanent for Medicare and encourages private insurers to follow suit, especially benefiting rural and underserved communities.

2.2 Mental Health and Substance Use Disorder Expansions#

Recognizing the growing mental health crisis, H.R. 26 includes several provisions to expand access to care:

  • Increased Funding for Community Mental Health Centers: The bill allocates $1 billion over five years to community mental health centers (CMHCs), which serve low-income and underserved populations. This funding would support hiring more clinicians, expanding hours, and adding specialized services for children and adolescents.
  • Medicaid Behavioral Health Expansion: H.R. 26 requires states to cover a broader range of mental health and substance use disorder services under Medicaid, including intensive outpatient care and peer support programs.
  • Opioid Crisis Response: The bill provides $500 million for opioid treatment and prevention initiatives, including medication-assisted treatment (MAT) programs and overdose prevention services. It also strengthens penalties for illegal opioid distribution.

2.3 Public Health Infrastructure Improvements#

H.R. 26 aims to strengthen the nation’s ability to respond to public health emergencies and reduce health disparities:

  • Public Health Agency Funding: The bill invests $2.5 billion in the Centers for Disease Control and Prevention (CDC) and state health departments to improve disease surveillance, emergency response, and health equity initiatives.
  • Health Disparity Grants: It establishes a grant program to address health disparities among marginalized groups, including racial and ethnic minorities, rural residents, and people with disabilities. Grants would fund community-based initiatives like mobile clinics and preventive care outreach.
  • Workforce Development: The bill provides funding for training programs to increase the number of healthcare workers in underserved areas, particularly primary care providers and mental health clinicians.

Legislative Journey: Current Status of H.R. 26#

3.1 Introduction and Committee Review#

H.R. 26 was introduced on January 9, 2023, and referred to four House committees: Energy and Commerce, Ways and Means, Education and Labor, and Oversight and Accountability.

In June 2023, the Energy and Commerce Committee approved the bill with a vote of 32–23, including several bipartisan amendments. These amendments included expanding telehealth access for veterans and adding provisions to address maternal health disparities.

3.2 Floor Action and Next Steps#

As of April 2024, H.R. 26 has not yet been scheduled for a full vote on the House floor. House leadership has indicated that it may be brought up for consideration alongside other healthcare-related bills to build broader support.

If passed by the House, the bill would move to the Senate, where it will likely undergo further amendments and negotiation. Senate Democrats have expressed support for some provisions (like the insulin cap) but may push for even broader drug price negotiation than what H.R. 26 proposes.

3.3 Potential Hurdles to Passage#

Several challenges could delay or derail H.R. 26:

  • Partisan Disagreements: While the bill has some bipartisan support, Republicans and Democrats disagree on the scope of drug price negotiation and funding sources. Some Republicans argue that expanding Medicare negotiation could reduce pharmaceutical innovation, while Democrats want to include more drugs in the program.
  • Senate Opposition: Senate Republicans may block the bill if it includes provisions they view as overreach, and Senate Democrats may push for changes that could alienate House Republicans.
  • Pharmaceutical Industry Lobbying: The pharmaceutical industry has spent millions opposing expanded drug price negotiation, which could influence lawmakers’ votes.

Why H.R. 26 Matters for Individuals and Communities#

For individuals, H.R. 26 could mean:

  • Lower out-of-pocket costs for prescription drugs, including insulin.
  • Easier access to mental health services, especially for those in rural areas.
  • No surprise bills for medical procedures.

For communities, the bill could:

  • Strengthen local public health agencies to respond to outbreaks like COVID-19 or flu.
  • Reduce health disparities by funding community-based care initiatives.
  • Create jobs in healthcare by supporting workforce development programs.

Overall, H.R. 26 has the potential to make meaningful progress toward a more affordable, accessible, and equitable healthcare system for all Americans.

Frequently Asked Questions (FAQs)#

Q: Who introduced H.R. 26?#

A: H.R. 26 was introduced by Representative Buddy Carter (R-Georgia) in the 118th Congress.

Q: Will H.R. 26 lower my healthcare costs?#

A: If passed, the bill would likely lower costs for many Americans, particularly those who take insulin or high-cost prescription drugs. It also helps reduce surprise billing and expands telehealth access, which can cut travel and appointment costs.

Q: Is H.R. 26 a bipartisan bill?#

A: While introduced by a Republican, the bill has received some bipartisan support in committee. However, negotiations are ongoing to address concerns from both parties, and final passage may require further compromises.

Q: When could H.R. 26 become law?#

A: The timeline is uncertain. It first needs to pass the full House of Representatives, then move to the Senate for consideration. If passed by both chambers, it would need to be signed by the President to become law. This process could take months or longer, depending on negotiation progress.

References#

2026-05

Thelegalist Team

Welcome to Thelegalist, where our team of dedicated professionals brings clarity to the complexities of the law.

Legal Disclaimer

No content on this website should be considered legal advice, as legal guidance must be tailored to the unique circumstances of each case. You should not act on any information provided by Thelegalist without first consulting a professional attorney who is licensed or authorized to practice in your jurisdiction. Thelegalist assumes no responsibility for any individual who relies on the information found on or received through this site and disclaims all liability regarding such information.

Although we strive to keep the information on this site up-to-date, the owners and contributors of this site make no representations, promises, or guarantees about the accuracy, completeness, or adequacy of the information contained on or linked to from this site.